Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to $3.5 million.

  • Healthcare Triangle's Receivables - Other rose 36384.11% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 36384.11%. This contributed to the annual value of $138000.0 for FY2024, which is 5460.53% down from last year.
  • According to the latest figures from Q3 2025, Healthcare Triangle's Receivables - Other is $3.5 million, which was up 36384.11% from $3.3 million recorded in Q2 2025.
  • Healthcare Triangle's 5-year Receivables - Other high stood at $3.5 million for Q3 2025, and its period low was $14000.0 during Q4 2023.
  • Its 5-year average for Receivables - Other is $1.1 million, with a median of $886151.5 in 2021.
  • Per our database at Business Quant, Healthcare Triangle's Receivables - Other plummeted by 9869.77% in 2023 and then skyrocketed by 450606.06% in 2025.
  • Healthcare Triangle's Receivables - Other (Quarter) stood at $816000.0 in 2021, then surged by 31.74% to $1.1 million in 2022, then plummeted by 98.7% to $14000.0 in 2023, then surged by 3450.0% to $497000.0 in 2024, then surged by 604.63% to $3.5 million in 2025.
  • Its Receivables - Other stands at $3.5 million for Q3 2025, versus $3.3 million for Q2 2025 and $1.5 million for Q1 2025.